Background Current guidelines recommend screening all people living with human
immunodeficiency virus (PLHIV) who have a CD4 count≤ 100 cells/µL for cryptococcal …

Cryptococcal meningitis is a life‐threatening opportunistic fungal infection in both HIV‐
infected and HIV‐uninfected patients. According to the most recent taxonomy, the …

Invasive fungal diseases (IFDs) are of huge concern in resource-limited settings, particularly
in Africa, due to the unavailability of diagnostic armamentarium for IFDs, thus making …

Background Cryptococcal meningitis (CM) and disseminated histoplasmosis (DH) are
common in people with human immunodeficiency virus (PWH) and diagnosed by detecting …

Cryptococcal antigen (CrAg) screening and targeted preemptive fluconazole in antiretroviral-
naive human immunodeficiency virus–infected adults with CD4 cell counts< 100/μL seems …

Background The global annual estimate for cryptococcal disease-related deaths exceeds
180,000, with three fourth occurring in sub-Saharan Africa. The World Health Organization …

Background Cryptococcal meningitis is a major cause of HIV/AIDS-related deaths in Africa.
Cryptococcosis is a neglected killer. However, meningitis can be prevented by early …

Fungal infections are increasingly becoming common and yet often neglected in developing
countries. Information on the burden of these infections is important for improved patient …

Background: Screening individuals with AIDS for serum cryptococcal antigen (CrAg),
followed by treatment of CrAg positives with antifungals, may prevent cryptococcal …

Cryptococcosis remains a significant cause of morbidity and mortality among HIV-infected
patients, especially in sub-Saharan Africa where it causes up to 20% of AIDS-related deaths …